{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:33:57Z","timestamp":1792654437795,"version":"4.5.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T00:00:00Z","timestamp":1435276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0131281","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T18:41:06Z","timestamp":1435344066000},"page":"e0131281","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Targeted Overexpression of \u03b1-Synuclein by rAAV2\/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse"],"prefix":"10.1371","volume":"10","author":[{"given":"Lian-Kun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-He","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Yun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,26]]},"reference":[{"issue":"6645","key":"ref1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"MG Spillantini","year":"1997","journal-title":"Nature"},{"issue":"5321","key":"ref2","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"MH Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"5646","key":"ref3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"\u03b1-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"A Singleton","year":"2003","journal-title":"Science"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"J Simon-Sanchez","year":"2009","journal-title":"Nature genetics"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00439-008-0582-9","article-title":"Genomewide association study for susceptibility genes contributing to familial Parkinson disease","volume":"124","author":"N Pankratz","year":"2009","journal-title":"Hum Genet"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of synuclein in the nigrostriatal system","volume":"22","author":"D Kirik","year":"2002","journal-title":"journal of neuroscience"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1471-4159.2001.00149.x","article-title":"Effect of the overexpression of wild-type or mutant \u03b1-synuclein on cell susceptibility to insult","volume":"76","author":"M Lee","year":"2001","journal-title":"Journal of neurochemistry"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01418-5","article-title":"Aggregates from mutant and wild-type \u03b1-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of \u03b2-sheet and amyloid-like filaments","volume":"440","author":"O El-Agnaf","year":"1998","journal-title":"FEBS letters"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neurobiolaging.2006.11.017","article-title":"Selective loss of nigral dopamine neurons induced by overexpression of truncated human \u03b1-synuclein in mice","volume":"29","author":"M Wakamatsu","year":"2008","journal-title":"Neurobiology of aging"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","article-title":"Lack of nigral pathology in transgenic mice expressing human \u03b1-synuclein driven by the tyrosine hydroxylase promoter","volume":"8","author":"Y Matsuoka","year":"2001","journal-title":"Neurobiol Dis"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.nbd.2004.07.001","article-title":"Alpha-synuclein and transgenic mouse models","volume":"17","author":"P-O Fernagut","year":"2004","journal-title":"Neurobiol Dis"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal \u03b1-synucleinopathy induced by viral vector-mediated overexpression of human \u03b1-synuclein: a new primate model of Parkinson's disease","volume":"100","author":"D Kirik","year":"2003","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"16","key":"ref13","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1073\/pnas.152339799","article-title":"\u03b1-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease","volume":"99","author":"CL Bianco","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081426","article-title":"Morphological and behavioral impact of AAV2\/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system","volume":"8","author":"SE Gombash","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1750-3639.2003.tb00035.x","article-title":"Neuropathology and Neurodegeneration in Rodent Brain Induced by Lentiviral Vectormediated Overexpression of \u03b1-Synuclein","volume":"13","author":"E Lauwers","year":"2003","journal-title":"Brain pathology"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease","volume":"91","author":"M Yamada","year":"2004","journal-title":"J Neurochem"},{"issue":"44","key":"ref17","first-page":"1750","article-title":"rAAV2\/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration","volume":"8","author":"M Oliveras-Salva","year":"2013","journal-title":"Mol Neurodegener"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"e17698","DOI":"10.1371\/journal.pone.0017698","article-title":"Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein","volume":"6","author":"JB Koprich","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2011.12.038","article-title":"Use of viral vectors to create animal models for Parkinson's disease","volume":"48","author":"K Low","year":"2012","journal-title":"Neurobiol Dis"},{"key":"ref20","first-page":"18","article-title":"Viral Vector-Based Models of Parkinson's Disease","volume":"18","author":"A Van der Perren","year":"2014","journal-title":"Curr Top Behav Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuroscience.2011.01.038","article-title":"Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone","volume":"181","author":"P Mulcahy","year":"2011","journal-title":"Neuroscience"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"J Bove","year":"2005","journal-title":"NeuroRx"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?","volume":"30","author":"F Cicchetti","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"ref24","first-page":"35","article-title":"Mechanisms of MPTP toxicity","volume":"1","author":"S Przedborski","year":"1998","journal-title":"Mov Disord"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM198308043090511","article-title":"Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"309","author":"JW Langston","year":"1983","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0079-6123(10)84007-5","article-title":"The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future","volume":"184","author":"SH Fox","year":"2010","journal-title":"Prog Brain Res"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"V Jackson-Lewis","year":"2007","journal-title":"Nat Protoc"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/hep.20803","article-title":"rAAV-mediated stable expression of heme oxygenase-1 in stellate cells: a new approach to attenuate liver fibrosis in rats","volume":"42","author":"TY Tsui","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10571-007-9185-6","article-title":"Overexpressed alpha-synuclein regulated the nuclear factor-kappaB signal pathway","volume":"28","author":"Y Yuan","year":"2008","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbr.2005.04.011","article-title":"Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains","volume":"163","author":"R Haobam","year":"2005","journal-title":"Behav Brain Res"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"JR Cannon","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0091-3057(97)00028-2","article-title":"Forced swim test-induced neurochemical endocrine, and immune changes in the rat","volume":"58","author":"TJ Connor","year":"1997","journal-title":"Pharmacology, biochemistry, and behavior"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/j.1742-4658.2011.08093.x","article-title":"Modulation of alpha-synuclein aggregation by dopamine in the presence of MPTP and its metabolite","volume":"278","author":"PN Jethva","year":"2011","journal-title":"The FEBS journal"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"M Vila","year":"2000","journal-title":"J Neurochem"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neuro.2004.05.002","article-title":"Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration","volume":"25","author":"RE Drolet","year":"2004","journal-title":"Neurotoxicology"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"0016706","DOI":"10.1371\/journal.pone.0016706","article-title":"Resistance to MPTP-neurotoxicity in alpha-synuclein knockout mice is complemented by human alpha-synuclein and associated with increased beta-synuclein and Akt activation","volume":"6","author":"B Thomas","year":"2011","journal-title":"PloS one"},{"issue":"40","key":"ref37","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"JP Anderson","year":"2006","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of \u03b1-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"R Sharon","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00401-006-0104-6","article-title":"\u03b1-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers","volume":"112","author":"K Beyer","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"20","key":"ref40","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"E Kontopoulos","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuropharm.2013.07.035","article-title":"The nuclear accumulation of alpha-synuclein is mediated by importin alpha and promotes neurotoxicity by accelerating the cell cycle","volume":"82","author":"KL Ma","year":"2014","journal-title":"Neuropharmacology"},{"issue":"7","key":"ref42","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"M Goedert","year":"2001","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrn1199","article-title":"The role of \u03b1-synuclein in Parkinson's disease: insights from animal models","volume":"4","author":"E Maries","year":"2003","journal-title":"Nature Reviews Neuroscience"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons","volume":"45","author":"M Decressac","year":"2012","journal-title":"Neurobiology of disease"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2007.08.006","article-title":"In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease?","volume":"209","author":"MF Chesselet","year":"2008","journal-title":"Exp Neurol"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"K Chiba","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"ref47","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"JA Javitch","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","article-title":"MPTP as a mitochondrial neurotoxic model of Parkinson's disease","volume":"36","author":"S Przedborski","year":"2004","journal-title":"J Bioenerg Biomembr"},{"issue":"1\u20132","key":"ref49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","article-title":"Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease","volume":"98","author":"DW Luchtman","year":"2009","journal-title":"Physiol Behav"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1073\/pnas.0711053105","article-title":"The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease","volume":"105","author":"OS Gorbatyuk","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"H Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuroscience.2009.03.002","article-title":"Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice","volume":"160","author":"H Schell","year":"2009","journal-title":"Neuroscience"},{"issue":"34","key":"ref53","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1074\/jbc.M802223200","article-title":"Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death","volume":"283","author":"N Sugeno","year":"2008","journal-title":"J Biol Chem"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-4159.2009.06191.x","article-title":"Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis","volume":"110","author":"KY Chau","year":"2009","journal-title":"J Neurochem"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"L Chen","year":"2005","journal-title":"Nat Neurosci"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1471-4159.2012.07769.x","article-title":"Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease","volume":"122","author":"W Xie","year":"2012","journal-title":"J Neurochem"},{"issue":"30","key":"ref57","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"HM Gao","year":"2008","journal-title":"J Neurosci"},{"issue":"5688","key":"ref58","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant \u03b1-synuclein by chaperone-mediated autophagy","volume":"305","author":"AM Cuervo","year":"2004","journal-title":"Science"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","article-title":"Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome","volume":"31","author":"E Emmanouilidou","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"6109","key":"ref60","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"KC Luk","year":"2012","journal-title":"Science"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"C Hansen","year":"2011","journal-title":"J Clin Invest"},{"issue":"48","key":"ref62","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"JC Watts","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"ref63","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"P Desplats","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"ref64","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of \u03b1-synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"W Dauer","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1046\/j.1471-4159.2001.00366.x","article-title":"Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice","volume":"77","author":"S Rathke-Hartlieb","year":"2001","journal-title":"J Neurochem"},{"issue":"1","key":"ref66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/neu.10094","article-title":"Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP","volume":"53","author":"Z Dong","year":"2002","journal-title":"J Neurobiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0131281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T19:14:49Z","timestamp":1566933289000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0131281"}},"subtitle":[],"editor":[{"given":"Philipp J.","family":"Kahle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,26]]},"references-count":66,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0131281","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,26]]}}}